[1] Bar-shalom R, Valdivia AY, Blaufox MD.PET imaging in oncology[J].Semin Nucl Med, 2000, 30(3):150-185.
[2] Liu RS.Clinical application of [C-11] acetate in oncology[J].Clin Positron Imaging, 2000, 3(4):185.
[3] Lapela M, Leskinen-Kallio S, Varpula M, et al.Metabolic imaging of ovarian tumors with carbon-11-methionme:a PET study[J].J Nucl Med, 1995, 36(12):2196-2200.
[4] Clavo AC, Brown RS, Wahl RL.Fluorodeoxyglucosc uptakc in human cancer cell lines is increased by hypoxia[J].J Nucl Med, 1995, 36(9):1625-1632.
[5] Torizuka T, Clavo AC, Wahl Rl.Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine[J].J Nucl Med, 1997.38(3):382-386.
[6] Hubner KF, McDonald TW, Niethammer JG, et al.Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-18F-deoxyglucose (2-18F-FDG)[J].Gynecol Oncol, 1993, 51(2):197-204.
[7] Yuan CC, Liu RS, Wang PH, et al.Whole-bod PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma.Initial report[J].J Reprod Med, 1999, 44(9):775-778.
[8] Delaloye AB.Radioimmunoimaging and radioim-munotherapy:with these be routin procedures?[J].Semin Nucl Med, 2000, 30(3):186-194.
[9] Kubik-Huch RA, Dorffler W, von Schulthess GK, et al.Value of (18F)-FDG positron emission tomography, computed tomography and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma[J].Eur Radiol, 2000, 10(5):761-767.
[10] Fenchel S, Kotzerke J, Stohr I, et al.Preoperative assessment of asymptomatic adnexal tumors bypositron emission tomography and F-18-fluo-rodeoxyglucosc[J].Nuklearmedizin, 1999, 38(4):101-107.
[11] Zimny M, Schroder W, Wolters S, et al.18F-fluo-rodeoxyglucose PET in ovarian carcinoma:methodology and preliminary results[J].Nuklearmedizin, 1997, 36(7):228-233.
[12] Romer W, Avril N, Oose J, et al.Metabolic characterization of ovarian tumors with positron-emission to-mography and F-18 fluorodeoxyglucose[J].Rofo Fortschr Geb Rontgenstr Neuen Bildgeb V erfahr, 1997, 166(1):62-68.
[13] Schroder W, Zimny M, Rudlowski C, et al.The role of 18F-fluoro-deoxyglucose positron emission tomog-raphy (18F-FDG PET) in diagnosis of ovarian cancer[J].Int J Gynecol Cancer, 1999, 9(2):117-122.
[14] Grab D, Flock F, Stohr I, et al.Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography[J].Gynecol Oncol, 2000, 77(3):454-459.